Retrospective study on the presence of spasticity-plus syndrome in the advanced practice nurse’s office in multiple sclerosis

Haydee Goicochea Briceño1, Yolanda Higueras1, José Manuel García Domínguez1, Ariana Meldaña Rivera1, Juan Pablo Cuello1, Elda Alba Suárez1, María Luisa Martínez Ginés1
1Servicio de Neurología, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Tài liệu tham khảo

Fernández, 2020, The broad concept of “spasticity-plus syndrome” in multiple sclerosis: a possible new concept in the management of multiple sclerosis symptoms, Front Neurol, 11, 152, 10.3389/fneur.2020.00152 Young, 1994, Spasticity: a review, Neurology, 44, S12 Mechoulam, 2013, The endocannabinoid system and the brain, Annu Rev Psychol, 64, 21, 10.1146/annurev-psych-113011-143739 Moreira, 2008, The endocannabinoid system: emotion, learning and addiction: the endocannabinoid system, Addict Biol, 13, 196, 10.1111/j.1369-1600.2008.00104.x Patti, 2022, A real‐world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: analysis in relation to the newly described ‘spasticity‐plus syndrome’, Eur J Neurol, 29, 2744, 10.1111/ene.15412 Ficha técnica Sativex 2,7 mg/2,5 mg solución para pulverización bucal. Aemps.es [Accessed 13 March 2023]. Available from: https://cima.aemps.es/cima/dochtml/ft/72544/FT_72544.html. Svíženská, 2008, Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures-a short review, Pharmacol Biochem Behav, 90, 501, 10.1016/j.pbb.2008.05.010 Fernández-Pablos, 2013, Manejo de los síntomas asociados a la espasticidad en pacientes con esclerosis múltiple, Enferm Clín, 26, 351 Truini, 2013, A mechanism-based classification of pain in multiple sclerosis, J Neurol, 260, 351, 10.1007/s00415-012-6579-2 Fernandez, 2021, Integrated management of multiple sclerosis spasticity and associated symptoms using the spasticity-Plus syndrome concept: results of a structured specialists’ discussion using the Workmat® methodology, Front Neurol, 12, 722801, 10.3389/fneur.2021.722801 Bruno, 2021, Theoretical and therapeutic implications of the spasticity-plus syndrome model in multiple sclerosis, Front Neurol, 12, 802918, 10.3389/fneur.2021.802918 Balci, 2018, Spasticity measurement, Noro Psikiyatr Ars, 55, S49 Farrar, 2008, Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial, Clin Ther, 30, 974, 10.1016/j.clinthera.2008.05.011